Your session is about to expire
← Back to Search
Impella-CP LV Vent for Cardiogenic Shock (REVERSE Trial)
REVERSE Trial Summary
This trial is testing whether adding a left ventricular assist device (Impella CP) to veno-arterial extracorporeal membrane oxygenation (VA-ECMO) improves survival and cardiac recovery in cardiogenic shock patients.
- Cardiogenic Shock
REVERSE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.REVERSE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a sudden tear in the wall of your aorta (the main artery in your body).You have recently had a stroke or are suspected of having a serious neurological injury.You had a mechanical problem that required surgery while on ECMO (a type of life support machine), such as a hole in the heart after a heart attack.Your body temperature is too low.You have a mechanical heart valve.You are experiencing heart failure caused by breathing problems.You recently had heart surgery and are experiencing severe heart failure.If you have a heart device called Impella 2.5, CP, 3.5 or 5.0 already implanted, you cannot participate.You have a heart condition that is getting worse despite medical treatment and causing shock and heart failure.If CPR lasts for more than 20-30 minutes, you will not be eligible for the trial unless your neurological status is satisfactory.You have severe pulmonary hypertension or are in a state of shock.
- Group 1: Control
- Group 2: Experimental
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this inquiry accommodate individuals aged 65 and above?
"This medical trial seeks individuals aged 18 to 65, with 13 studies available for patients under the legal age of consent and 132 trials targeting those beyond retirement age."
Is there still an opportunity for individuals to join this clinical research?
"This specific medical trial, which was initially posted on March 19th of 2018 and last updated November 4th 2022, is no longer recruiting. However, clinicaltrials.gov currently lists over a hundred and forty two other studies actively seeking participants."
Who is eligible to participate in this scientific research?
"This clinical trial seeks to include 96 individuals aged 18-65 suffering from cardiogenic shock due to Post-acute myocardial infarction, drug overdose, early graft failure post orthotropic heart transplantation or acute on chronic cardiomyopathy with progressive shock and decompensation. Candidates must have no mechanical complications requiring surgical intervention after extracorpeal membrane oxygenator (ECMO) such as post-ischaemic ventricular septal defect (VSD)."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger